162 related articles for article (PubMed ID: 16219326)
41. Attenuation of Gi- and Gq-mediated signaling by expression of RGS4 or GAIP in mammalian cells.
Huang C; Hepler JR; Gilman AG; Mumby SM
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6159-63. PubMed ID: 9177187
[TBL] [Abstract][Full Text] [Related]
42. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide.
Shimohigashi Y; Hatano R; Fujita T; Nakashima R; Nose T; Sujaku T; Saigo A; Shinjo K; Nagahisa A
J Biol Chem; 1996 Sep; 271(39):23642-5. PubMed ID: 8798582
[TBL] [Abstract][Full Text] [Related]
43. RGS2 and RGS4 proteins: New modulators of the κ-opioid receptor signaling.
Papakonstantinou MP; Karoussiotis C; Georgoussi Z
Cell Signal; 2015 Jan; 27(1):104-14. PubMed ID: 25289860
[TBL] [Abstract][Full Text] [Related]
44. Lack of mu-opioid receptor-mediated G-protein activation in the spinal cord of mice lacking Exon 1 or Exons 2 and 3 of the MOR-1 gene.
Mizoguchi H; Wu HE; Narita M; Sora I; Hall SF; Uhl GR; Loh HH; Nagase H; Tseng LF
J Pharmacol Sci; 2003 Dec; 93(4):423-9. PubMed ID: 14737012
[TBL] [Abstract][Full Text] [Related]
45. The nociceptin receptor inhibits axonal regeneration and recovery from spinal cord injury.
Sekine Y; Siegel CS; Sekine-Konno T; Cafferty WBJ; Strittmatter SM
Sci Signal; 2018 Apr; 11(524):. PubMed ID: 29615517
[TBL] [Abstract][Full Text] [Related]
46. An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19.
Shaw VS; Mohammadi M; Quinn JA; Vashisth H; Neubig RR
Mol Pharmacol; 2019 Dec; 96(6):683-691. PubMed ID: 31543506
[TBL] [Abstract][Full Text] [Related]
47. Heterodimerization of apelin and opioid receptor-like 1 receptors mediates apelin-13-induced G protein biased signaling.
Chen J; Wang Z; Zhang R; Yin H; Wang P; Wang C; Jiang Y
Life Sci; 2023 Sep; 328():121892. PubMed ID: 37364634
[TBL] [Abstract][Full Text] [Related]
48. Opioid activity profiles indicate similarities between the nociceptin/orphanin FQ and opioid receptors.
Hawkinson JE; Acosta-Burruel M; Espitia SA
Eur J Pharmacol; 2000 Feb; 389(2-3):107-14. PubMed ID: 10688973
[TBL] [Abstract][Full Text] [Related]
49. Molecular characterization and functional expression of opioid receptor-like1 receptor.
Wu YL; Pu L; Ling K; Zhao J; Cheng ZJ; Ma L; Pei G
Cell Res; 1997 Jun; 7(1):69-77. PubMed ID: 9261564
[TBL] [Abstract][Full Text] [Related]
50. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
[TBL] [Abstract][Full Text] [Related]
51. 5-HT1A receptor-mediated phosphorylation of extracellular signal-regulated kinases (ERK1/2) is modulated by regulator of G protein signaling protein 19.
Wang Q; Terauchi A; Yee CH; Umemori H; Traynor JR
Cell Signal; 2014 Sep; 26(9):1846-52. PubMed ID: 24793302
[TBL] [Abstract][Full Text] [Related]
52. Structural basis for the selectivity of the RGS protein, GAIP, for Galphai family members. Identification of a single amino acid determinant for selective interaction of Galphai subunits with GAIP.
Woulfe DS; Stadel JM
J Biol Chem; 1999 Jun; 274(25):17718-24. PubMed ID: 10364213
[TBL] [Abstract][Full Text] [Related]
53. Tritium-labelled isovaleryl-RYYRIK-NH2 as potential antagonist probe for ORL1 nociceptin receptor.
Inamine S; Nishimura H; Li J; Isozaki K; Matsushima A; Costa T; Shimohigashi Y
Bioorg Med Chem; 2014 Nov; 22(21):5902-9. PubMed ID: 25284251
[TBL] [Abstract][Full Text] [Related]
54. beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells.
Mandyam CD; Altememi GF; Standifer KM
Eur J Pharmacol; 2000 Aug; 402(1-2):R1-37. PubMed ID: 10940375
[TBL] [Abstract][Full Text] [Related]
55. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.
Georgoussi Z; Leontiadis L; Mazarakou G; Merkouris M; Hyde K; Hamm H
Cell Signal; 2006 Jun; 18(6):771-82. PubMed ID: 16120478
[TBL] [Abstract][Full Text] [Related]
56. Modulation of Ca2+ channels by opioid receptor-like 1 receptors natively expressed in rat stellate ganglion neurons innervating cardiac muscle.
Ruiz-Velasco V; Puhl HL; Fuller BC; Sumner AD
J Pharmacol Exp Ther; 2005 Sep; 314(3):987-94. PubMed ID: 15937148
[TBL] [Abstract][Full Text] [Related]
57. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.
Sim LJ; Childers SR
J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852
[TBL] [Abstract][Full Text] [Related]
58. Constitutive activation of the opioid receptor-like (ORL1) receptor by mutation of Asn133 to tryptophan in the third transmembrane region.
Kam KW; New DC; Wong YH
J Neurochem; 2002 Dec; 83(6):1461-70. PubMed ID: 12472900
[TBL] [Abstract][Full Text] [Related]
59. Molecular modelling of the ORL1 receptor and its complex with nociceptin.
Topham CM; Moulédous L; Poda G; Maigret B; Meunier JC
Protein Eng; 1998 Dec; 11(12):1163-79. PubMed ID: 9930666
[TBL] [Abstract][Full Text] [Related]
60. Opioid receptor signalling mechanisms.
Connor M; Christie MD
Clin Exp Pharmacol Physiol; 1999 Jul; 26(7):493-9. PubMed ID: 10405772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
